Klockgether, T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 9, 94–104 (2010).
Article PubMed CAS Google Scholar
Teive, H. A. G. & Ashizawa, T. Primary and secondary ataxias. Curr. Opin. Neurol. 28, 413–422 (2015).
Article PubMed PubMed Central Google Scholar
Coarelli, G. et al. The inherited cerebellar ataxias: an update. J. Neurol. 270, 208–222 (2023).
Divya, K. P. & Kishore, A. Treatable cerebellar ataxias. Clin. Park. Relat. Disord. 3, 100053 (2020).
Muñiz-Castrillo, S. et al. Novelties in autoimmune and paraneoplastic cerebellar ataxias: twenty years of progresses. Cerebellum 21, 573–591 (2022).
Mitoma, H., Hadjivassiliou, M. & Honnorat, J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias 2, 14 (2015).
Article PubMed PubMed Central Google Scholar
Joubert, B. & Honnorat, J. Nonparaneoplastic autoimmune cerebellar ataxias. Curr. Opin. Neurol. 32, 484–492 (2019).
Hadjivassiliou, M. et al. Diagnostic criteria for primary autoimmune cerebellar ataxia — guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum 19, 605–610 (2020).
Article PubMed PubMed Central Google Scholar
Narayan, R. N., McKeon, A. & Fife, T. D. Autoimmune vestibulocerebellar syndromes. Semin. Neurol. 40, 97–115 (2020).
Simard, C. et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol. Neuroimmunol. Neuroinflamm. 7, e699 (2020).
Article PubMed PubMed Central Google Scholar
Irani, S. R. et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133, 2734–2748 (2010).
Article PubMed PubMed Central Google Scholar
Lancaster, E. et al. Investigations of CASPR2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 69, 303–311 (2011).
Article PubMed PubMed Central CAS Google Scholar
Joubert, B. et al. Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurol. Neuroimmunol. Neuroinflamm. 4, e371 (2017).
Article PubMed PubMed Central Google Scholar
Becker, E. B. et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 83, 437–440 (2012).
Benoit, J. et al. Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis. Neurol. Neuroimmunol. Neuroinflamm. 10, e200041 (2023).
Mandel-Brehm, C. et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N. Engl. J. Med. 381, 47–54 (2019).
Article PubMed PubMed Central CAS Google Scholar
Hadjivassiliou, M., Sanders, D. S., Woodroofe, N., Williamson, C. & Grünewald, R. A. Gluten ataxia. Cerebellum 7, 494–498 (2008).
Article PubMed CAS Google Scholar
Gaig, C. et al. Clinical manifestations of the anti-IgLON5 disease. Neurology 88, 1736–1743 (2017).
Article PubMed PubMed Central CAS Google Scholar
Honorat, J. A. et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol. Neuroimmunol. Neuroinflamm. 4, e385 (2017).
Article PubMed PubMed Central Google Scholar
Gaig, C. et al. Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97, e1367–e1381 (2021).
Article PubMed PubMed Central CAS Google Scholar
Mitoma, H., Manto, M. & Hadjivassiliou, M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J. Mov. Disord. 14, 10–28 (2021).
Article PubMed PubMed Central Google Scholar
Chan, J. L., Murphy, K. A. & Sarna, J. R. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J. Neurol. 268, 3517–3548 (2021).
Article PubMed PubMed Central CAS Google Scholar
Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).
Montalban, X. et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N. Engl. J. Med. 376, 209–220 (2017).
Article PubMed CAS Google Scholar
Pittock, S. J. et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133, 2626–2634 (2010).
Tobin, W. O. et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 140, 2415–2425 (2017).
Mitoma, H. & Manto, M. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms. J. Neurol. 271, 7046–7053 (2024).
Krismer, F., Fanciulli, A., Meissner, W. G., Coon, E. A. & Wenning, G. K. Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. Lancet Neurol. 23, 1252–1266 (2024).
Bogdan, T. et al. Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study. J. Neurol. 269, 6354–6365 (2022).
Article PubMed CAS Google Scholar
Oender, D. et al. Evolution of clinical outcome measures and biomarkers in sporadic adult-onset degenerative ataxia. Mov. Disord. 38, 654–664 (2023).
Article PubMed CAS Google Scholar
Wenning, G. K. et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov. Disord. 37, 1131–1148 (2022).
Article PubMed PubMed Central Google Scholar
Virameteekul, S., Revesz, T., Jaunmuktane, Z., Warner, T. T. & De Pablo-Fernández, E. Pathological validation of the MDS criteria for the diagnosis of multiple system atrophy. Mov. Disord. 38, 444–452 (2023).
Sekiya, H. et al. Validation study of the MDS criteria for the diagnosis of multiple system atrophy in the Mayo Clinic Brain Bank. Neurology 101, e2460–e2471 (2023).
Article PubMed PubMed Central CAS Google Scholar
Teive, H. A. G., Arruda, W. O., Moro, A., Moscovich, M. & Munhoz, R. P. Differential diagnosis of sporadic adult-onset ataxia: the role of REM sleep behavior disorder. Parkinsonism Relat. Disord. 21, 640–643 (2015).
Comments (0)